1. 39P The expanded CD8+ tumor-infiltrating lymphocyte tumor-specific granzyme response is dominated by granzyme B. (December 2022) Authors: Rasmussen, A-C.K.; Chamberlain, C.; Harbst, K.; Khan, S.; Schina, A.; Draghi, A.; Presti, M.; Jensen, A.W.P.; Jönsson, G.; Svane, I-M.; Donia, M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The clinical significance of BRAF and NRAS mutations in a clinic‐based metastatic melanoma cohort. (31st October 2013) Authors: Ekedahl, H.; Cirenajwis, H.; Harbst, K.; Carneiro, A.; Nielsen, K.; Olsson, H.; Lundgren, L.; Ingvar, C.; Jönsson, G. Journal: British journal of dermatology Issue: Volume 169:Number 5(2013:Nov.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗